Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res.?(2023) 191 107112].
Sullivan J, Gunning B, Zafar M, Guerrini R, Gecz J, Kolc KL, Zhao Y, Gasior M, Aimetti AA, Samanta D. Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res.?(2023) 191 107112]. Epilepsy Res. 2024 Jul; 203:107342.